Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
March 14, 2019 Off

European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy for First-Line Treatment of Adults with Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)

By BusinessWire

European Approval Based on KEYNOTE-407 Study Results Demonstrating
Significant Improvement in Overall Survival with KEYTRUDA in Combination
with Chemotherapy Compared to Chemotherapy Alone

KEYTRUDA is First Anti-PD-…

March 14, 2019 Off

Solasia Files New Medical Device Application for episil® in South Korea

By BusinessWire

TOKYO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/OM?src=hash" target="_blank"gt;#OMlt;/agt;–Solasia Pharma K.K. (TOKYO:4597, Headquarters:Tokyo, Japan, President &
CEO:Yoshihiro Arai, hereinafter “Solasia”)…

March 14, 2019 Off

Methycobal Tablets – Drug Insight, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Methycobal
Tablets – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Methycobal Tablets Drug Insight, 2019 highlights the
drug marketed details and the G…

March 14, 2019 Off

Sipralexoro – Drug Insight, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Sipralexoro
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Sipralexoro Drug Insight, 2019 highlights the drug
marketed details and the Global API Manu…

March 14, 2019 Off

Sevikar – Drug Insight, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Sevikar
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Sevikar Drug Insight, 2019 highlights the drug marketed
details and the Global API Manufacturer…

March 14, 2019 Off

Skelaxin – Drug Insight, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Skelaxin
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Skelaxin Drug Insight, 2019 highlights the drug
marketed details and the Global API Manufactur…

March 14, 2019 Off

Erbitux – Drug Insight, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Erbitux
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Erbitux Drug Insight, 2019 highlights the drug marketed
details and the Global API Manufacturer…

March 14, 2019 Off

Tracleer – Drug Insight, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Tracleer
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Tracleer Drug Insight, 2019 highlights the drug
marketed details and the Global API Manufactur…

March 14, 2019 Off

Amitiza – Drug Insight, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Amitiza
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Amitiza Drug Insight, 2019 highlights the drug marketed
details and the Global API Manufacturer…

March 14, 2019 Off

BeneFIX – Drug Insight, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “BeneFIX
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

BeneFIX Drug Insight, 2019 highlights the drug marketed
details and the Global API Manufacturer…

Posts pagination

Previous 1 … 3,359 3,360 3,361 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine